Oragenics, Inc. announced that the Board of Directors approved the appointment of Janet Huffman, as the Company's new Secretary and Treasurer. Ms. Huffman entered into an Executive Employment Agreement with the Company under the terms substantially similar to the employment agreements of existing executives. Under the terms of her Executive Employment Agreement, Ms. Huffman's employment with the Company became effective March 7, 2023 and she receives an annual base salary of $250,000 and will be eligible for a Performance Bonus with a target of 35% of her annual salary based on appropriate Company based and individual based targets in the discretion of the Compensation Committee as approved by the full Board of Directors.

Ms. Huffman will be eligible to participate in the medical insurance and other benefits available to all employees except her annual vacation will be set at four (4) weeks. The Executive Employment Agreement is terminable at any time by the Company and upon 60 days' notice by Ms. Huffman. Upon separation for any reason Ms. Huffman shall receive her base salary accrued through the date of termination, and any vested rights and benefits provided under employee benefit plans and programs of the Company.

In addition, if Ms. Huffman's separation from employment is terminated by the Company without Cause or for non-renewal by the Company after the end of the Initial Term and Ms. Huffman signs a full general release then the Company would be obligated to pay Ms. Huffman six months of her annual base salary as severance plus any earned but unpaid Performance Bonus. If Ms. Huffman's employment is terminated by the Company without Cause during the period of 30 days following a Change in Control and Ms. Huffman signs a full general release then the Company would be obligated to pay Ms. Huffman six months of her annual base salary as severance, any earned, accrued but unpaid bonus Performance Bonus and Ms. Huffman's Performance Bonus for the year of the Change in Control at target level of performance. Additionally, with any such termination Ms. Huffman's stock options or other stock awards under the Company's 2021 Equity Incentive Plan which are not vested shall vest as of her termination date.

Under the Executive Employment Agreement, Change in Control" is defined as a transaction or series of transactions which constitutes a sale of control of the Company, a change in effective control of the Company, or a sale of all or substantially all of the assets of the Company, or a transaction which qualifies as a change in ownership" or change in effective control" of the Company or a change in ownership of substantially all of the assets" of the Company under the standards set forth in Treasury Regulation section 1.409A-3(i)(5). In the Executive Employment Agreement Ms. Huffman has agreed to duties of non-disclosure of Confidential Information, non-competition and non-solicitation and Company ownership of developments provisions.